Loss-of-PLEKHN1 probably causes severe phenotypes in tumor, however, the endogenous colorectal expressions of PLEKHN1 were not high, this could be involved in the general drug resistance of colorectal cancer. This evidence concerns the gene PLEKHN1 and neoplasm.